Correlation Between Immix Biopharma and AVROBIO

Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and AVROBIO at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and AVROBIO into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Immix Biopharma and AVROBIO, you can compare the effects of market volatilities on Immix Biopharma and AVROBIO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of AVROBIO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and AVROBIO.

Diversification Opportunities for Immix Biopharma and AVROBIO

0.21

Correlation Coefficient

Immix Biopharma  AVROBIO

Modest diversification

The 3 months correlation between Immix and AVROBIO is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and AVROBIO in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AVROBIO and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with AVROBIO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AVROBIO has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and AVROBIO go up and down completely randomly.

Pair Corralation between Immix Biopharma and AVROBIO

Given the investment horizon of 90 days Immix Biopharma is expected to generate 1.59 times less return on investment than AVROBIO. But when comparing it to its historical volatility, Immix Biopharma is 1.16 times less risky than AVROBIO. It trades about 0.04 of its potential returns per unit of risk. AVROBIO is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  80.00  in AVROBIO on September 4, 2024 and sell it today you would earn a total of  60.00  from holding AVROBIO or generate 75.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	76.97%
Values	Daily Returns

Immix Biopharma  vs.  AVROBIO

Immix Biopharma

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Immix Biopharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting primary indicators, Immix Biopharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

AVROBIO

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AVROBIO has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, AVROBIO is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Immix Biopharma and AVROBIO

The main advantage of trading using opposite Immix Biopharma and AVROBIO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, AVROBIO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVROBIO will offset losses from the drop in AVROBIO's long position.

The idea behind Immix Biopharma and AVROBIO pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.